Description
The Department of Veterans Affairs intends to enter into a sole source procurement with Illumina Inc. to provide SeqCure Enterprise wide variant sequencing for SARS-COV-2 Sequencing Collaborations United for Research and Epidemiology Preventative Maintenance with full coverage support necessary for the Durham VA Medical Center. The contract will be for a period of performance of September 5, 2026 – September 4, 2027, with 4 Option Years. The NextSeq 2000 Next Generation Sequencer is core to the VA-SEQCURE program and requires annual Preventative Maintenance (PM) and Support to ensure continuing high accuracy, precision, and reproducibility.
• The contract is for a period of performance of September 5, 2026 – September 4, 2027, with 4 Option Years.
• The NextSeq 2000 Next Generation Sequencer is core to the VA-SEQCURE program.
• The instrument requires annual Preventative Maintenance (PM) and Support to ensure continuing high accuracy, precision, and reproducibility.
• The contract is intended to support the VA-SEQCURE program, an integrated enterprise effort to conduct sequencing and other protocols to facilitate research and apply the results of the collaborative research to combat COVID-19 as well as other emerging and re-emerging infectious diseases.